BET inhibition therapy counteracts cancer cell survival, clonogenic potential and radioresistance mechanisms in rhabdomyosarcoma cells
- 1 June 2020
- journal article
- research article
- Published by Elsevier BV in Cancer Letters
- Vol. 479, 71-88
- https://doi.org/10.1016/j.canlet.2020.03.011
Abstract
No abstract availableFunding Information
- “Io…domani, Associazione Onlus per la Lotta contro i Tumori Infantili” (ALTI), Rome, Italy
- “Associazione Onlus Fabrizio Procaccini”, Rome, Italy
- Progetti di Ricerca di Ateneo 2018 (RM1181642707D875)
- Sapienza University of Rome, Rome, Italy
This publication has 76 references indexed in Scilit:
- MiR-124 Suppresses Growth of Human Colorectal Cancer by Inhibiting STAT3PLOS ONE, 2013
- Alveolar rhabdomyosarcoma – The molecular drivers of PAX3/7-FOXO1-induced tumorigenesisSkeletal Muscle, 2012
- Maintenance of tumor initiating cells of defined genetic composition by nucleosteminProceedings of the National Academy of Sciences of the United States of America, 2011
- Vincristine, Actinomycin, and Cyclophosphamide Compared With Vincristine, Actinomycin, and Cyclophosphamide Alternating With Vincristine, Topotecan, and Cyclophosphamide for Intermediate-Risk Rhabdomyosarcoma: Children's Oncology Group Study D9803Journal of Clinical Oncology, 2009
- Trends in childhood rhabdomyosarcoma incidence and survival in the United States, 1975‐2005Cancer, 2009
- γH2AX and cancerNature Reviews Cancer, 2008
- Glioma stem cells promote radioresistance by preferential activation of the DNA damage responseNature, 2006
- Novel Genes Implicated in Embryonal, Alveolar, and Pleomorphic Rhabdomyosarcoma: A Cytogenetic and Molecular Analysis of Primary TumorsNeoplasia, 2006
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Rhabdomyosarcoma – working out the pathwaysOncogene, 1999